Byhealth Co., Ltd (SHE:300146)
China · Delayed Price · Currency is CNY 9.82
+0.13 (1.34%)
Jun 18, 2026, 3:04 PM CST
Byhealth Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Byhealth stock has a consensus rating of "Strong Buy" and an average price target of ¥12.85. The average 1-year stock price forecast is 30.86% higher than the current stock price, while the lowest is ¥10.30 (+4.89%) and the highest is ¥14.56 (+48.27%).
Price Target: ¥12.85 (+30.86%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Byhealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Oct '25 | Nov '25 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 8 | 5 | 5 |
Financial Forecast
Revenue This Year
6.99B
from 6.27B
Increased by 11.62%
Revenue Next Year
7.63B
from 6.99B
Increased by 9.14%
EPS This Year
0.50
from 0.41
Increased by 21.95%
EPS Next Year
0.59
from 0.50
Increased by 17.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.1B | ||
| Avg | 7.0B | ||
| Low | 6.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.3% | ||
| Avg | 11.6% | ||
| Low | 10.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.50 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 22.0% | ||
| Low | - |